FindMyRecallSubscribe
Class I: serious health riskTerminated

Apotex Piperacillin and Tazobactam for Injection Recall

Piperacillin and Tazobactam for Injection, USP 4

Apotex Inc.

Risk level
Class I
Reported by FDA
May 23, 2018
Recall ID
D-0840-2018
Check your lot numberHow we source this data

Summary

Apotex recalled Piperacillin and Tazobactam for Injection starting May 8, 2018. The FDA classified it as Class I (serious health risk) and published enforcement report D-0840-2018 on May 23, 2018. Reason: Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency. Status: Terminated.

Why it was recalled

Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency

Product description

Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4

Lot numbers, UPCs & expiration codes

Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.

Where it was sold

Nationwide in the USA.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0840-2018
Classification
Class I
Status
Terminated
Recall initiated
May 8, 2018
FDA report date
May 23, 2018
Quantity
13453 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Apotex Inc.

Original FDA data

Every field from FDA enforcement report D-0840-2018, exactly as published.

Show all FDA fields
City
North York
Status
Terminated
Country
Canada
Event ID
80063
Address
150 Signet Dr
Code information
Lots: 502H001 Exp. 01/2019; 502H003, 502H004, 502H005, Exp. 04/2019; 502H009, 502H012, Exp. 05/2019.
Report date
May 23, 2018
Product type
Drugs
Recall number
D-0840-2018
Classification
Class I
Recalling firm
Apotex Inc.
Product quantity
13453 vials
Termination date
Oct 3, 2023
Reason for recall
Subpotent Drug: High Levels of Impurities Resulting in Decrease Potency
Voluntary / mandated
Voluntary: Firm initiated
Product description
Piperacillin and Tazobactam for Injection, USP 4.5 gram/vial* 10-count Single Use Vials per carton, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd. Irungattukottai-602 105, India Mfg. for: Apotex Corp. Weston, FL 33326. NDC 60505-0688-4
Distribution pattern
Nationwide in the USA.
Recall initiation date
May 8, 2018
Initial firm notification
Letter
Center classification date
Jun 5, 2018

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0840-2018, published May 23, 2018. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls